Events & Presentations

Corporate Presentation

January 2017
download

CHI 14th Annual Discovery On Target – Targeting Cardio-Metabolic Diseases

Thyroid Hormone Receptor Beta (THR-├č) Agonist for NASH: Correcting a Primary Deficiency in NASH Livers. A presentation by┬áMadrigal Chief Medical Officer and Executive Vice President, R&D, Rebecca Taub, MD.
September 21, 2016 | Boston, MA